Complete solution for the COVID-19 response

In response to the rapidly evolving COVID-19 pandemic and upcoming flu season, Seegene is committed to continuously develop and support effective tools for the fight against this global pandemic.

Complete solution for the COVID-19 response

Accurate COVID-19 testing is essential for reducing the spread of SARS-CoV-2, the coronavirus that causes COVID-19, and for appropriate patient care.

Seegene’s COVID-19 solutions, which include multiple target genes for SARS-CoV-2, are multiplex real-time PCR assays intended for the detection of nucleic acids from SARS-CoV-2 in upper respiratory specimens (nasopharyngeal swab, oropharyngeal swab, aspirate and etc.) and lower respiratory specimens (sputum, bronchoalveolar lavage) from patients suspected of COVID-19. The solutions can be applied on Seegene’s All-in-One automated platform that enables high-throughput testing.

Analytes

Allplex™ 2019-nCoV Assay

  • – N gene
  • – RdRP gene
  • – E gene
  • – Internal control (IC)

Allplex™ SARS-CoV-2 Assay

  • – N gene
  • – S gene
  • – RdRP gene
  • – E gene
  • – Internal control (IC)

Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay

  • – N gene
  • – S gene
  • – RdRP gene
  • – Influenza A
  • – Influenza B
  • – RSV A/B
  • – Endogenous internal control (IC)
  • – Exogenous internal control (IC)

Overview of product selection criteria

Overview of product selection criteria

Allplex™ SARS-CoV-2 Assay can be used alone or compatible with high multiplex respiratory essential panel for other common respiratory infections, including influenza A and B, metapneumovirus, parainfluenza virus 1/2/3/4, adenovirus, rhinovirus A/B/C and respiratory syncytial virus A/B, to provide more insights for diagnosis of symptomatic patients.

Primary screening for COVID-19, Flu and RSV

Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay is designed to detect and differentiate between SARS-CoV-2, influenza A, influenza B and RSV for primary screening during the upcoming flu season.

More reliable results using dual internal controls

– The endogenous and exogenous internal controls are designed to verify  the entire process from sample collection to nucleic acid extraction and PCR steps

– The endogenous internal control enables validating correct sampling for self-collected specimens

Seegene OVERCOMM*
web-based statistic program

Seegene is supporting extensive clinical studies in multi-sites and multi-nation on a combined test of the most common respiratory viruses and SARS-CoV-2 from influenza like illness patient’s specimens.

It would help meet the global interests and needs for a comprehensive understanding of the syndromic test related to respiratory pathogens including SARS-CoV-2. The program is designed to simply visualize the prevalence of pathogens and demonstrate cases of multiple pathogens infection.

Analytes

Allplex™ 2019-nCoV Assay

  • – N gene
  • – RdRP gene
  • – E gene
  • – Internal control (IC)

Allplex™ SARS-CoV-2 Assay

  • – N gene
  • – S gene
  • – RdRP gene
  • – E gene
  • – Internal control (IC)

Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay

  • – N gene
  • – S gene
  • – RdRP gene
  • – Influenza A
  • – Influenza B
  • – RSV A/B
  • – Endogenous internal control (IC)
  • – Exogenous internal control (IC)

Powerful automation platform

Seegene’s automated molecular diagnostic platform allows a unique streamlined workflow with quick and simple steps for detection of COVID-19.

STARlet IVD or NIMBUS IVD

Automated Extraction & PCR Setup

CFX96TM

Detection by Real-time PCR

Seegene Viewer

Automated Data Analysis
Visitors Count: 8163